Contrasting Ex Vivo Efficacies of “Reversed Chloroquine” Compounds in Chloroquine-Resistant Plasmodium falciparum and P. vivax Isolates

Chloroquine (CQ) has been the mainstay of malaria treatment for more than 60 years. However, the emergence and spread of CQ resistance now restrict its use to only a few areas where malaria is endemic. The aim of the present study was to investigate whether a novel combination of a CQ-like moiety an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Antimicrob Agents Chemother
Prif Awduron: Wirjanata, Grennady, Sebayang, Boni F., Chalfein, Ferryanto, Prayoga, Handayuni, Irene, Noviyanti, Rintis, Kenangalem, Enny, Poespoprodjo, Jeanne Rini, Burgess, Steven J., Peyton, David H., Price, Ric N., Marfurt, Jutta
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2015
Pynciau:
Susceptibility
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538531/
https://ncbi.nlm.nih.gov/pubmed/26149984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01048-15
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg